Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Vaccines

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 259 articles: HTML format

Single Articles

July 2021
1. LOPEZ BERNAL J, Andrews N, Gower C, Gallagher E, et al
   Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
   N Engl J Med. 2021 Jul 21. doi: 10.1056/NEJMoa2108891.
   PubMed     Abstract available
   
   
   
2. MADHI SA, Izu A, Pollard AJ
   ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant. Reply.
   N Engl J Med. 2021;385.
   PubMed    
   
   
   
3. STRUYF F, Sadoff J, Douoguih M
   ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant.
   N Engl J Med. 2021;385.
   PubMed    
   
   
   
4. EVANS SJW, Jewell NP
   Vaccine Effectiveness Studies in the Field.
   N Engl J Med. 2021 Jul 21. doi: 10.1056/NEJMe2110605.
   PubMed    
   
   
   
5. MOON S, Alonso Ruiz A, Vieira M
   Averting Future Vaccine Injustice.
   N Engl J Med. 2021;385:193-196.
   PubMed    
   
   
   
6. RUBIN EJ, Baden LR, Morrissey S
   Audio Interview: Monoclonal Antibodies and Vaccine Boosts.
   N Engl J Med. 2021;385:e18.
   PubMed    
   
   
   
7. EICHINGER S, Warkentin TE, Greinacher A
   Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. Reply.
   N Engl J Med. 2021;385:e11.
   PubMed    
   
   
   
8. CHOI PY
   Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
   N Engl J Med. 2021;385:e11.
   PubMed    
   
   
   
9. LAI KY, Au SY, Fong KM
   Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
   N Engl J Med. 2021;385:e11.
   PubMed    
   
   
   
10. NORMARK J, Vikstrom L, Gwon YD, Persson IL, et al
    Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.
    N Engl J Med. 2021 Jul 14. doi: 10.1056/NEJMc2110716.
    PubMed    
    
    
    
11. BAROUCH DH, Stephenson KE, Sadoff J, Yu J, et al
    Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination.
    N Engl J Med. 2021 Jul 14. doi: 10.1056/NEJMc2108829.
    PubMed    
    
    
    
12. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: How Well Are Covid-19 Vaccines Working?
    N Engl J Med. 2021;385:e15.
    PubMed    
    
    
    
13. BRINKLEY-RUBINSTEIN L, Peterson M, Martin R, Chan P, et al
    Breakthrough SARS-CoV-2 Infections in Prison after Vaccination.
    N Engl J Med. 2021 Jul 7. doi: 10.1056/NEJMc2108479.
    PubMed    
    
    
    
14. PATRIQUIN CJ, Laroche V, Selby R, Pendergrast J, et al
    Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    N Engl J Med. 2021 Jul 7. doi: 10.1056/NEJMc2109465.
    PubMed    
    
    
    
15. JARA A, Undurraga EA, Gonzalez C, Paredes F, et al
    Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile.
    N Engl J Med. 2021 Jul 7. doi: 10.1056/NEJMoa2107715.
    PubMed     Abstract available
    
    
    
16. EDARA VV, Pinsky BA, Suthar MS, Lai L, et al
    Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.
    N Engl J Med. 2021 Jul 7. doi: 10.1056/NEJMc2107799.
    PubMed    
    
    
    
17. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Another New Covid-19 Vaccine.
    N Engl J Med. 2021;385:e13.
    PubMed    
    
    
    
18. ROPPER AH, Klein JP
    Cerebral Venous Thrombosis.
    N Engl J Med. 2021;385:59-64.
    PubMed    
    
    
    June 2021
19. THOMPSON MG, Burgess JL, Naleway AL, Tyner H, et al
    Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
    N Engl J Med. 2021 Jun 30. doi: 10.1056/NEJMoa2107058.
    PubMed     Abstract available
    
    
    
20. HEATH PT, Galiza EP, Baxter DN, Boffito M, et al
    Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.
    N Engl J Med. 2021 Jun 30. doi: 10.1056/NEJMoa2107659.
    PubMed     Abstract available
    
    
    
21. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A New mRNA Vaccine.
    N Engl J Med. 2021;384:e109.
    PubMed    
    
    
    
22. HARRIS RJ, Hall JA, Zaidi A, Andrews NJ, et al
    Effect of Vaccination on Household Transmission of SARS-CoV-2 in England.
    N Engl J Med. 2021 Jun 23. doi: 10.1056/NEJMc2107717.
    PubMed    
    
    
    
23. KAMAR N, Abravanel F, Marion O, Couat C, et al
    Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients.
    N Engl J Med. 2021 Jun 23. doi: 10.1056/NEJMc2108861.
    PubMed    
    
    
    
24. KRAUSE PR, Fleming TR, Longini IM, Peto R, et al
    SARS-CoV-2 Variants and Vaccines.
    N Engl J Med. 2021 Jun 23. doi: 10.1056/NEJMsr2105280.
    PubMed     Abstract available
    
    
    
25. KOENIG PA, Schmidt FI
    Spike D614G - A Candidate Vaccine Antigen Against Covid-19.
    N Engl J Med. 2021;384:2349-2351.
    PubMed    
    
    
    
26. RILEY LE
    mRNA Covid-19 Vaccines in Pregnant Women.
    N Engl J Med. 2021;384:2342-2343.
    PubMed    
    
    
    
27. 
    SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    N Engl J Med. 2021;384:e92.
    PubMed    
    
    
    
28. RUBIN EJ, Baden LR, Longo DL, Morrissey S, et al
    Audio Interview: Treating Complications of Covid Vaccination.
    N Engl J Med. 2021;384:e107.
    PubMed    
    
    
    
29. BOURGUIGNON A, Arnold DM, Warkentin TE, Smith JW, et al
    Adjunct Immune Globulin for Vaccine-Induced Thrombotic Thrombocytopenia.
    N Engl J Med. 2021 Jun 9. doi: 10.1056/NEJMoa2107051.
    PubMed     Abstract available
    
    
    
30. VANDEBOSCH A, Sadoff J, Douoguih M
    Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. Reply.
    N Engl J Med. 2021 Jun 9. pii: 10.1056/NEJMc2107809.
    PubMed    
    
    
    
31. HEININGER U
    Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
    N Engl J Med. 2021 Jun 9. pii: 10.1056/NEJMc2107809.
    PubMed    
    
    
    
32. SAMARAKOON U, Alvarez-Arango S, Blumenthal KG
    Delayed Large Local Reactions to mRNA Covid-19 Vaccines in Blacks, Indigenous Persons, and People of Color.
    N Engl J Med. 2021 Jun 9. doi: 10.1056/NEJMc2108620.
    PubMed    
    
    
    
33. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Vaccinating Children.
    N Engl J Med. 2021;384:e103.
    PubMed    
    
    
    
34. TAPIA MD, Sow SO, Naficy A, Diallo F, et al
    Meningococcal Serogroup ACWYX Conjugate Vaccine in Malian Toddlers.
    N Engl J Med. 2021;384:2115-2123.
    PubMed     Abstract available
    
    
    
35. NEWMAN AM
    Institutional Problems, Individual Solutions - The Burden on Black Physicians.
    N Engl J Med. 2021;384:2076-2078.
    PubMed    
    
    
    
36. BLACHERE NE, Hacisuleyman E, Darnell RB
    Vaccine Breakthrough Infections with SARS-CoV-2 Variants. Reply.
    N Engl J Med. 2021 Jun 2. pii: 10.1056/NEJMc2107808.
    PubMed    
    
    
    
37. RANA K, Mohindra R, Pinnaka L
    Vaccine Breakthrough Infections with SARS-CoV-2 Variants.
    N Engl J Med. 2021 Jun 2. pii: 10.1056/NEJMc2107808.
    PubMed    
    
    
    
38. NIXON DF, Ndhlovu LC
    Vaccine Breakthrough Infections with SARS-CoV-2 Variants.
    N Engl J Med. 2021 Jun 2. pii: 10.1056/NEJMc2107808.
    PubMed    
    
    
    
39. TAKUVA S, Takalani A, Garrett N, Goga A, et al
    Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study.
    N Engl J Med. 2021 Jun 2. doi: 10.1056/NEJMc2107920.
    PubMed    
    
    
    May 2021
40. FRENCK RW JR, Klein NP, Kitchin N, Gurtman A, et al
    Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.
    N Engl J Med. 2021 May 27. doi: 10.1056/NEJMoa2107456.
    PubMed     Abstract available
    
    
    
41. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Protecting the Immunosuppressed against Covid-19.
    N Engl J Med. 2021;384:e88.
    PubMed    
    
    
    
42. VOLPP KG, Cannuscio CC
    Incentives for Immunity - Strategies for Increasing Covid-19 Vaccine Uptake.
    N Engl J Med. 2021 May 26. doi: 10.1056/NEJMp2107719.
    PubMed    
    
    
    
43. RUBIN EJ, Baden LR, Drazen JM, Taichman DB, et al
    Audio Interview: Vaccination in Nursing Homes and New Pulmonary/Critical Care Research.
    N Engl J Med. 2021;384:e89.
    PubMed    
    
    
    
44. VAYNE C, Rollin J, Gruel Y, Pouplard C, et al
    PF4 Immunoassays in Vaccine-Induced Thrombotic Thrombocytopenia.
    N Engl J Med. 2021 May 19. doi: 10.1056/NEJMc2106383.
    PubMed    
    
    
    
45. WHITE EM, Yang X, Blackman C, Feifer RA, et al
    Incident SARS-CoV-2 Infection among mRNA-Vaccinated and Unvaccinated Nursing Home Residents.
    N Engl J Med. 2021 May 19. doi: 10.1056/NEJMc2104849.
    PubMed    
    
    
    
46. RUBIN EJ, Baden LR, Gray GE, Morrissey S, et al
    Audio Interview: Vaccination and Variants in the U.S. and South Africa.
    N Engl J Med. 2021;384:e85.
    PubMed    
    
    
    
47. KEEHNER J, Abeles SR, Torriani FJ
    More on SARS-CoV-2 Infection after Vaccination in Health Care Workers. Reply.
    N Engl J Med. 2021 May 12. pii: 10.1056/NEJMc2106004.
    PubMed    
    
    
    
48. TOSONI A, Mirijello A, Addolorato G
    More on SARS-CoV-2 Infection after Vaccination in Health Care Workers.
    N Engl J Med. 2021 May 12. pii: 10.1056/NEJMc2106004.
    PubMed    
    
    
    
49. CHIN ET, Leidner D, Ryckman T, Liu YE, et al
    Covid-19 Vaccine Acceptance in California State Prisons.
    N Engl J Med. 2021 May 12. doi: 10.1056/NEJMc2105282.
    PubMed    
    
    
    
50. RUBIN EJ, Baden LR, Udwadia ZF, Morrissey S, et al
    Audio Interview: India's Covid-19 Crisis.
    N Engl J Med. 2021;384:e84.
    PubMed    
    
    
    
51. RATZAN S, Schneider EC, Hatch H, Cacchione J, et al
    Missing the Point - How Primary Care Can Overcome Covid-19 Vaccine "Hesitancy".
    N Engl J Med. 2021 May 5. doi: 10.1056/NEJMp2106137.
    PubMed    
    
    
    
52. SHINDE V, Bhikha S, Hoosain Z, Archary M, et al
    Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant.
    N Engl J Med. 2021 May 5. doi: 10.1056/NEJMoa2103055.
    PubMed     Abstract available
    
    
    
53. ABU-RADDAD LJ, Chemaitelly H, Butt AA
    Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants.
    N Engl J Med. 2021 May 5. doi: 10.1056/NEJMc2104974.
    PubMed    
    
    
    
54. NEUZIL KM
    Interplay between Emerging SARS-CoV-2 Variants and Pandemic Control.
    N Engl J Med. 2021 May 5. doi: 10.1056/NEJMe2103931.
    PubMed    
    
    
    April 2021
55. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Advice for Clinicians on Covid-19 Vaccines and Social Restrictions.
    N Engl J Med. 2021;384:e77.
    PubMed    
    
    
    
56. GOLDFARB JL, Kreps S, Brownstein JS, Kriner DL, et al
    Beyond the First Dose - Covid-19 Vaccine Follow-through and Continued Protective Measures.
    N Engl J Med. 2021 Apr 28. doi: 10.1056/NEJMp2104527.
    PubMed    
    
    
    
57. RUBIN EJ, Baden LR, Walensky RP, Morrissey S, et al
    Audio Interview: Covid-19 Vaccines and Pregnancy - A Conversation with CDC Director Rochelle Walensky.
    N Engl J Med. 2021;384:e73.
    PubMed    
    
    
    
58. BLUMENTHAL KG, Saff RR, Freeman EE
    Delayed Large Local Reactions to mRNA Vaccines. Reply.
    N Engl J Med. 2021 Apr 21. pii: 10.1056/NEJMc2104751.
    PubMed    
    
    
    
59. BAECK M, Marot L, Belkhir L
    Delayed Large Local Reactions to mRNA Vaccines.
    N Engl J Med. 2021 Apr 21. pii: 10.1056/NEJMc2104751.
    PubMed    
    
    
    
60. BARDA N, Dagan N, Balicer RD
    BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. Reply.
    N Engl J Med. 2021;384.
    PubMed    
    
    
    
61. ROEST S, Hoek RAS, Manintveld OC
    BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.
    N Engl J Med. 2021;384.
    PubMed    
    
    
    
62. SADOFF J, Gray G, Vandebosch A, Cardenas V, et al
    Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
    N Engl J Med. 2021 Apr 21. doi: 10.1056/NEJMoa2101544.
    PubMed     Abstract available
    
    
    
63. HACISULEYMAN E, Hale C, Saito Y, Blachere NE, et al
    Vaccine Breakthrough Infections with SARS-CoV-2 Variants.
    N Engl J Med. 2021 Apr 21. doi: 10.1056/NEJMoa2105000.
    PubMed     Abstract available
    
    
    
64. SHIMABUKURO TT, Kim SY, Myers TR, Moro PL, et al
    Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons.
    N Engl J Med. 2021 Apr 21. doi: 10.1056/NEJMoa2104983.
    PubMed     Abstract available
    
    
    
65. SCULLY M, Singh D, Lown R, Poles A, et al
    Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination.
    N Engl J Med. 2021 Apr 16. doi: 10.1056/NEJMoa2105385.
    PubMed     Abstract available
    
    
    
66. CINES DB, Bussel JB
    SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    N Engl J Med. 2021 Apr 16. doi: 10.1056/NEJMe2106315.
    PubMed    
    
    
    
67. SADOFF J, Davis K, Douoguih M
    Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination - Response from the Manufacturer.
    N Engl J Med. 2021 Apr 16. doi: 10.1056/NEJMc2106075.
    PubMed    
    
    
    
68. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Vaccine Successes and Vaccine Adverse Events.
    N Engl J Med. 2021;384:e70.
    PubMed    
    
    
    
69. ROSENBAUM L
    No Cure without Care - Soothing Science Skepticism.
    N Engl J Med. 2021;384:1462-1465.
    PubMed    
    
    
    
70. LIU Y, Liu J, Xia H, Zhang X, et al
    Neutralizing Activity of BNT162b2-Elicited Serum.
    N Engl J Med. 2021;384:1466-1468.
    PubMed    
    
    
    
71. MUIR KL, Kallam A, Koepsell SA, Gundabolu K, et al
    Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination.
    N Engl J Med. 2021 Apr 14. doi: 10.1056/NEJMc2105869.
    PubMed    
    
    
    
72. ANICHINI G, Terrosi C, Gandolfo C, Gori Savellini G, et al
    SARS-CoV-2 Antibody Response in Persons with Past Natural Infection.
    N Engl J Med. 2021 Apr 14. doi: 10.1056/NEJMc2103825.
    PubMed    
    
    
    
73. GREINACHER A, Thiele T, Warkentin TE, Weisser K, et al
    Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
    N Engl J Med. 2021 Apr 9. doi: 10.1056/NEJMoa2104840.
    PubMed     Abstract available
    
    
    
74. SCHULTZ NH, Sorvoll IH, Michelsen AE, Munthe LA, et al
    Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
    N Engl J Med. 2021 Apr 9. doi: 10.1056/NEJMoa2104882.
    PubMed     Abstract available
    
    
    
75. KATZ IT, Weintraub R, Bekker LG, Brandt AM, et al
    From Vaccine Nationalism to Vaccine Equity - Finding a Path Forward.
    N Engl J Med. 2021;384:1281-1283.
    PubMed    
    
    
    
76. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Antibody Responses to Natural Infection and Vaccination.
    N Engl J Med. 2021;384:e65.
    PubMed    
    
    
    
77. MOYO-GWETE T, Madzivhandila M, Makhado Z, Ayres F, et al
    Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351).
    N Engl J Med. 2021 Apr 7. doi: 10.1056/NEJMc2104192.
    PubMed    
    
    
    
78. LUSTIG Y, Nemet I, Kliker L, Zuckerman N, et al
    Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2.
    N Engl J Med. 2021 Apr 7. doi: 10.1056/NEJMc2104036.
    PubMed    
    
    
    
79. SHEN X, Tang H, Pajon R, Smith G, et al
    Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351.
    N Engl J Med. 2021 Apr 7. doi: 10.1056/NEJMc2103740.
    PubMed    
    
    
    
80. DORIA-ROSE N, Suthar MS, Makowski M, O'Connell S, et al
    Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19.
    N Engl J Med. 2021 Apr 6. doi: 10.1056/NEJMc2103916.
    PubMed    
    
    
    
81. WANG GL, Wang ZY, Duan LJ, Meng QC, et al
    Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization.
    N Engl J Med. 2021 Apr 6. doi: 10.1056/NEJMc2103022.
    PubMed    
    
    
    
82. RUBIN EJ, Baden LR, Del Rio C, Akusobi C, et al
    Audio Interview: Delivering Covid-19 Vaccines to Minority Communities.
    N Engl J Med. 2021;384:e60.
    PubMed    
    
    
    
83. MBALA-KINGEBENI P, Pratt C, Mutafali-Ruffin M, Pauthner MG, et al
    Ebola Virus Transmission Initiated by Relapse of Systemic Ebola Virus Disease.
    N Engl J Med. 2021;384:1240-1247.
    PubMed     Abstract available
    
    
    March 2021
84. QUINN SC, Andrasik MP
    Addressing Vaccine Hesitancy in BIPOC Communities - Toward Trustworthiness, Partnership, and Reciprocity.
    N Engl J Med. 2021 Mar 31. doi: 10.1056/NEJMp2103104.
    PubMed    
    
    
    
85. HALL MA, Studdert DM
    "Vaccine Passport" Certification - Policy and Ethical Considerations.
    N Engl J Med. 2021 Mar 31. doi: 10.1056/NEJMp2104289.
    PubMed    
    
    
    
86. NACHEGA JB, Sam-Agudu NA, Mellors JW, Zumla A, et al
    Scaling Up Covid-19 Vaccination in Africa - Lessons from the HIV Pandemic.
    N Engl J Med. 2021 Mar 31. doi: 10.1056/NEJMp2103313.
    PubMed    
    
    
    
87. DESMOND A, Offit PA
    On the Shoulders of Giants - From Jenner's Cowpox to mRNA Covid Vaccines.
    N Engl J Med. 2021;384:1081-1083.
    PubMed    
    
    
    
88. FEINBERG MB
    Uhambo - Twists and Turns on the Journey to an Efficacious HIV-1 Vaccine.
    N Engl J Med. 2021;384:1157-1159.
    PubMed    
    
    
    
89. GRAY GE, Bekker LG, Laher F, Malahleha M, et al
    Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults.
    N Engl J Med. 2021;384:1089-1100.
    PubMed     Abstract available
    
    
    
90. RUBIN EJ, Baden LR, Brandt AM, Morrissey S, et al
    Audio Interview: What Earlier Epidemics Teach Us about Covid-19.
    N Engl J Med. 2021;384:e55.
    PubMed    
    
    
    
91. ABDOOL KARIM SS, de Oliveira T
    New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications.
    N Engl J Med. 2021 Mar 24. doi: 10.1056/NEJMc2100362.
    PubMed    
    
    
    
92. KEEHNER J, Horton LE, Pfeffer MA, Longhurst CA, et al
    SARS-CoV-2 Infection after Vaccination in Health Care Workers in California.
    N Engl J Med. 2021 Mar 23. doi: 10.1056/NEJMc2101927.
    PubMed    
    
    
    
93. BRADLEY T, Grundberg E, Selvarangan R, LeMaster C, et al
    Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine.
    N Engl J Med. 2021 Mar 23. doi: 10.1056/NEJMc2102051.
    PubMed    
    
    
    
94. DANIEL W, Nivet M, Warner J, Podolsky DK, et al
    Early Evidence of the Effect of SARS-CoV-2 Vaccine at One Medical Center.
    N Engl J Med. 2021 Mar 23. doi: 10.1056/NEJMc2102153.
    PubMed    
    
    
    
95. BENENSON S, Oster Y, Cohen MJ, Nir-Paz R, et al
    BNT162b2 mRNA Covid-19 Vaccine Effectiveness among Health Care Workers.
    N Engl J Med. 2021 Mar 23. doi: 10.1056/NEJMc2101951.
    PubMed    
    
    
    
96. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Efficacy of Current Covid-19 Vaccines against Variant Viruses.
    N Engl J Med. 2021;384:e53.
    PubMed    
    
    
    
97. WU K, Werner AP, Koch M, Choi A, et al
    Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine.
    N Engl J Med. 2021 Mar 17. doi: 10.1056/NEJMc2102179.
    PubMed    
    
    
    
98. MADHI SA, Baillie V, Cutland CL, Voysey M, et al
    Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.
    N Engl J Med. 2021 Mar 16. doi: 10.1056/NEJMoa2102214.
    PubMed     Abstract available
    
    
    
99. RUBIN EJ, Baden LR, Abraham J, Morrissey S, et al
    Audio Interview: The Implications of Changes in the Structural Biology of SARS-CoV-2.
    N Engl J Med. 2021;384:e48.
    PubMed    
    
    
    
100. KRAMMER F, Srivastava K, Alshammary H, Amoako AA, et al
     Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine.
     N Engl J Med. 2021 Mar 10. doi: 10.1056/NEJMc2101667.
     PubMed    
     
     
     
101. GORALNICK E, Kaufmann C, Gawande AA
     Mass-Vaccination Sites - An Essential Innovation to Curb the Covid-19 Pandemic.
     N Engl J Med. 2021 Mar 10. doi: 10.1056/NEJMp2102535.
     PubMed    
     
     
     
102. RUBIN EJ, Baden LR, Morrissey S
     Audio Interview: A New SARS-CoV-2 Vaccine and a New Look at Treatment.
     N Engl J Med. 2021;384:e46.
     PubMed    
     
     
     
103. BLUMENTHAL KG, Freeman EE, Saff RR, Robinson LB, et al
     Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2.
     N Engl J Med. 2021 Mar 3. doi: 10.1056/NEJMc2102131.
     PubMed    
     
     
     
104. STEELFISHER GK, Blendon RJ, Caporello H
     An Uncertain Public - Encouraging Acceptance of Covid-19 Vaccines.
     N Engl J Med. 2021 Mar 3. doi: 10.1056/NEJMp2100351.
     PubMed    
     
     
     
105. BARSKY BA, Reinhart E, Farmer P, Keshavjee S, et al
     Vaccination plus Decarceration - Stopping Covid-19 in Jails and Prisons.
     N Engl J Med. 2021 Mar 3. doi: 10.1056/NEJMp2100609.
     PubMed    
     
     
     
106. KRAMER DB, Opel DJ, Parasidis E, Mello MM, et al
     Choices in a Crisis - Individual Preferences among SARS-CoV-2 Vaccines.
     N Engl J Med. 2021 Mar 3. doi: 10.1056/NEJMp2102146.
     PubMed    
     
     
     February 2021
107. RUBIN EJ, Baden LR, Morrissey S
     Audio Interview: The Real-World Effectiveness of Covid-19 Vaccination.
     N Engl J Med. 2021;384:e40.
     PubMed    
     
     
     
108. DAGAN N, Barda N, Kepten E, Miron O, et al
     BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.
     N Engl J Med. 2021 Feb 24. doi: 10.1056/NEJMoa2101765.
     PubMed     Abstract available
     
     
     
109. UBEL PA
     Vaccinating Health Care Employees - Do They All Deserve Early Access?
     N Engl J Med. 2021 Feb 19. doi: 10.1056/NEJMpv2101203.
     PubMed    
     
     
     
110. RUBIN EJ, Baden LR, Farrar JJ, Morrissey S, et al
     Audio Interview: Viral Variants and Covid-19.
     N Engl J Med. 2021;384:e38.
     PubMed    
     
     
     
111. ABSALON J, Koury K, Gruber WC
     Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. Reply.
     N Engl J Med. 2021;384.
     PubMed    
     
     
     
112. WANG X
     Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
     N Engl J Med. 2021;384.
     PubMed    
     
     
     
113. VERGNES JN
     Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
     N Engl J Med. 2021;384.
     PubMed    
     
     
     
114. SKOWRONSKI DM, De Serres G
     Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
     N Engl J Med. 2021;384.
     PubMed    
     
     
     
115. KADIRE SR, Wachter RM, Lurie N
     Delayed Second Dose versus Standard Regimen for Covid-19 Vaccination.
     N Engl J Med. 2021 Feb 17. doi: 10.1056/NEJMclde2101987.
     PubMed    
     
     
     
116. WU K, Werner AP, Koch M, Choi A, et al
     Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine - Preliminary Report.
     N Engl J Med. 2021 Feb 17. doi: 10.1056/NEJMc2102179.
     PubMed    
     
     
     
117. ROSENBAUM L
     Escaping Catch-22 - Overcoming Covid Vaccine Hesitancy.
     N Engl J Med. 2021 Feb 12. doi: 10.1056/NEJMms2101220.
     PubMed    
     
     
     
118. HALLEY MC, Mangurian C
     Caring for the Caregivers - Covid-19 Vaccination for Essential Members of the Health Care Team.
     N Engl J Med. 2021 Feb 12. doi: 10.1056/NEJMpv2101339.
     PubMed    
     
     
     
119. RUBIN EJ, Baden LR, Morrissey S
     Audio Interview: Does Vaccination Mean the End of Masking and Social Distancing?
     N Engl J Med. 2021;384:e32.
     PubMed    
     
     
     
120. PAGE K, Melia MT, Veenhuis RT, Winter M, et al
     Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection.
     N Engl J Med. 2021;384:541-549.
     PubMed     Abstract available
     
     
     
121. CASTELLS MC, Phillips EJ
     Maintaining Safety with SARS-CoV-2 Vaccines. Reply.
     N Engl J Med. 2021 Feb 10. pii: 10.1056/NEJMc2100766.
     PubMed    
     
     
     
122. ROLLA G, Brussino L, Badiu I
     Maintaining Safety with SARS-CoV-2 Vaccines.
     N Engl J Med. 2021 Feb 10. pii: 10.1056/NEJMc2100766.
     PubMed    
     
     
     
123. GERBERDING JL, Haynes BF
     Vaccine Innovations - Past and Future.
     N Engl J Med. 2021;384:393-396.
     PubMed    
     
     
     
124. RUBIN EJ, Baden LR, Northam RS, Morrissey S, et al
     Audio Interview: Covid-19 and the States - A Conversation with Ralph Northam.
     N Engl J Med. 2021;384:e25.
     PubMed    
     
     
     January 2021
125. RUBIN EJ, Baden LR, Fauci AS, Morrissey S, et al
     Audio Interview: A Covid-19 Conversation with Anthony Fauci.
     N Engl J Med. 2021;384:e22.
     PubMed    
     
     
     
126. LEE TH, Chen AH
     Last-Mile Logistics of Covid Vaccination - The Role of Health Care Organizations.
     N Engl J Med. 2021 Jan 27. doi: 10.1056/NEJMp2100574.
     PubMed    
     
     
     
127. HEATON PM
     The Covid-19 Vaccine-Development Multiverse. Reply.
     N Engl J Med. 2021;384.
     PubMed    
     
     
     
128. KOJIMA N, Turner I, Klausner JD
     The Covid-19 Vaccine-Development Multiverse.
     N Engl J Med. 2021;384.
     PubMed    
     
     
     
129. RUBIN EJ, Baden LR, Nottage K, O'Connell J, et al
     Audio Interview: An International Look at Covid-19.
     N Engl J Med. 2021;384:e19.
     PubMed    
     
     
     
130. KLASS P, Ratner AJ
     Vaccinating Children against Covid-19 - The Lessons of Measles.
     N Engl J Med. 2021 Jan 20. doi: 10.1056/NEJMp2034765.
     PubMed    
     
     
     
131. VAN TASSEL K, Shachar C, Hoffman S
     Covid-19 Vaccine Injuries - Preventing Inequities in Compensation.
     N Engl J Med. 2021 Jan 20. doi: 10.1056/NEJMp2034438.
     PubMed    
     
     
     
132. HUGHES MT, Kahn J, Kachalia A
     Who Goes First? Government Leaders and Prioritization of SARS-CoV-2 Vaccines.
     N Engl J Med. 2021 Jan 20. doi: 10.1056/NEJMpv2036128.
     PubMed    
     
     
     
133. BAJAJ SS, Stanford FC
     Beyond Tuskegee - Vaccine Distrust and Everyday Racism.
     N Engl J Med. 2021 Jan 20. doi: 10.1056/NEJMpv2035827.
     PubMed    
     
     
     
134. RUBIN EJ, Baden LR, Abdool Karim SS, Morrissey S, et al
     Audio Interview: Covid-19 in South Africa and a New SARS-CoV-2 Variant.
     N Engl J Med. 2021;384:e14.
     PubMed    
     
     
     
135. SADOFF J, Le Gars M, Shukarev G, Heerwegh D, et al
     Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine.
     N Engl J Med. 2021 Jan 13. doi: 10.1056/NEJMoa2034201.
     PubMed     Abstract available
     
     
     
136. RUBIN EJ, Baden LR, Lee TH, Morrissey S, et al
     Audio Interview: Planning for the SARS-CoV-2 Vaccine Rollout.
     N Engl J Med. 2021;384:e13.
     PubMed    
     
     
     
137. WOOD S, Schulman K
     Beyond Politics - Promoting Covid-19 Vaccination in the United States.
     N Engl J Med. 2021 Jan 6. doi: 10.1056/NEJMms2033790.
     PubMed    
     
     
     December 2020
138. RUBIN EJ, Baden LR, Morrissey S
     Audio Interview: A Look at Covid-19 Prevention and Care in 2020.
     N Engl J Med. 2020;383:e147.
     PubMed    
     
     
     
139. BADEN LR, El Sahly HM, Essink B, Kotloff K, et al
     Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
     N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMoa2035389.
     PubMed     Abstract available
     
     
     
140. HAYNES BF
     A New Vaccine to Battle Covid-19.
     N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMe2035557.
     PubMed    
     
     
     
141. FOPPIANO PALACIOS C, Travassos MA
     Vaccinating Detained Migrants against SARS-CoV-2 - Preventing Another Tragedy.
     N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMpv2035416.
     PubMed    
     
     
     
142. CASTELLS MC, Phillips EJ
     Maintaining Safety with SARS-CoV-2 Vaccines.
     N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMra2035343.
     PubMed    
     
     
     
143. BAROCAS JA
     Business Not as Usual - Covid-19 Vaccination in Persons with Substance Use Disorders.
     N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMpv2035709.
     PubMed    
     
     
     
144. RUBIN EJ, Baden LR, Morrissey S
     Audio Interview: Covid-19 Vaccine Fundamentals.
     N Engl J Med. 2020;383:e146.
     PubMed    
     
     
     
145. POLACK FP, Thomas SJ, Kitchin N, Absalon J, et al
     Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
     N Engl J Med. 2020 Dec 10. doi: 10.1056/NEJMoa2034577.
     PubMed     Abstract available
     
     
     
146. RUBIN EJ, Longo DL
     SARS-CoV-2 Vaccination - An Ounce (Actually, Much Less) of Prevention.
     N Engl J Med. 2020 Dec 10. doi: 10.1056/NEJMe2034717.
     PubMed    
     
     
     
147. RUBIN EJ, Baden LR, Barocas JA, Morrissey S, et al
     Audio Interview: SARS-CoV-2 Vaccination and Vulnerable Populations.
     N Engl J Med. 2020;383:e143.
     PubMed    
     
     
     
148. WIDGE AT, Rouphael NG, Jackson LA, Anderson EJ, et al
     Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.
     N Engl J Med. 2020 Dec 3. doi: 10.1056/NEJMc2032195.
     PubMed    
     
     
     
149. KRAUSE PR, Fleming TR, Longini IM, Peto R, et al
     Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them.
     N Engl J Med. 2020 Dec 2. doi: 10.1056/NEJMp2033538.
     PubMed    
     
     
     November 2020
150. RUBIN EJ, Baden LR, Haug CJ, Morrissey S, et al
     Audio Interview: Covid-19 in Europe and New Information on Vaccines.
     N Engl J Med. 2020;383:e134.
     PubMed    
     
     
     
151. REDDY SN, Nair NP, Tate JE, Thiyagarajan V, et al
     Intussusception after Rotavirus Vaccine Introduction in India.
     N Engl J Med. 2020;383:1932-1940.
     PubMed     Abstract available
     
     
     
152. RUBIN EJ, Baden LR, Woodcock J, Morrissey S, et al
     Audio Interview: An Update from Operation Warp Speed.
     N Engl J Med. 2020;383:e127.
     PubMed    
     
     
     
153. RUBIN EJ, Baden LR, Morrissey S
     Audio Interview: What the U.S. Response to Covid-19 Looks Like Today.
     N Engl J Med. 2020;383:e123.
     PubMed    
     
     
     October 2020
154. HALABI S, Heinrich A, Omer SB
     No-Fault Compensation for Vaccine Injury - The Other Side of Equitable Access to Covid-19 Vaccines.
     N Engl J Med. 2020 Oct 28. doi: 10.1056/NEJMp2030600.
     PubMed    
     
     
     
155. STRASSLE C, Jardas E, Ochoa J, Berkman BE, et al
     Covid-19 Vaccine Trials and Incarcerated People - The Ethics of Inclusion.
     N Engl J Med. 2020 Oct 21. doi: 10.1056/NEJMp2025955.
     PubMed    
     
     
     
156. KRAUSE PR, Gruber MF
     Emergency Use Authorization of Covid Vaccines - Safety and Efficacy Follow-up Considerations.
     N Engl J Med. 2020 Oct 16. doi: 10.1056/NEJMp2031373.
     PubMed    
     
     
     
157. WARREN RC, Forrow L, Hodge DA Sr, Truog RD, et al
     Trustworthiness before Trust - Covid-19 Vaccine Trials and the Black Community.
     N Engl J Med. 2020 Oct 16. doi: 10.1056/NEJMp2030033.
     PubMed    
     
     
     
158. RUBIN EJ, Baden LR, Morrissey S
     Audio Interview: Vaccinology and Covid-19.
     N Engl J Med. 2020;383:e109.
     PubMed    
     
     
     
159. WALSH EE, Frenck RW Jr, Falsey AR, Kitchin N, et al
     Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.
     N Engl J Med. 2020 Oct 14. doi: 10.1056/NEJMoa2027906.
     PubMed     Abstract available
     
     
     
160. LEI J, Ploner A, Elfstrom KM, Wang J, et al
     HPV Vaccination and the Risk of Invasive Cervical Cancer.
     N Engl J Med. 2020;383:1340-1348.
     PubMed     Abstract available
     
     
     September 2020
161. ANDERSON EJ, Rouphael NG, Widge AT, Jackson LA, et al
     Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.
     N Engl J Med. 2020 Sep 29. doi: 10.1056/NEJMoa2028436.
     PubMed     Abstract available
     
     
     
162. CHRISTIE A, Neatherlin JC, Nichol ST, Beach M, et al
     Ebola Response Priorities in the Time of Covid-19.
     N Engl J Med. 2020;383:1202-1204.
     PubMed    
     
     
     
163. SCHWARTZ JL
     Evaluating and Deploying Covid-19 Vaccines - The Importance of Transparency, Scientific Integrity, and Public Trust.
     N Engl J Med. 2020 Sep 23. doi: 10.1056/NEJMp2026393.
     PubMed    
     
     
     
164. AVORN J, Kesselheim AS
     Up Is Down - Pharmaceutical Industry Caution vs. Federal Acceleration of Covid-19 Vaccine Approval.
     N Engl J Med. 2020 Sep 15. doi: 10.1056/NEJMp2029479.
     PubMed    
     
     
     
165. RUBIN EJ, Baden LR, Morrissey S
     Audio Interview: Guidelines for Covid-19 Vaccine Deployment.
     N Engl J Med. 2020;383:e88.
     PubMed    
     
     
     
166. GANDHI M, Rutherford GW
     Facial Masking for Covid-19 - Potential for "Variolation" as We Await a Vaccine.
     N Engl J Med. 2020 Sep 8. doi: 10.1056/NEJMp2026913.
     PubMed    
     
     
     
167. BLOOM BR, Nowak GJ, Orenstein W
     "When Will We Have a Vaccine?" - Understanding Questions and Answers about Covid-19 Vaccination.
     N Engl J Med. 2020 Sep 8. doi: 10.1056/NEJMp2025331.
     PubMed    
     
     
     
168. KEECH C, Albert G, Cho I, Robertson A, et al
     Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine.
     N Engl J Med. 2020 Sep 2. doi: 10.1056/NEJMoa2026920.
     PubMed     Abstract available
     
     
     August 2020
169. RUBIN EJ, Baden LR, Morrissey S
     Audio Interview: Operation Warp Speed and Covid-19.
     N Engl J Med. 2020;383:e79.
     PubMed    
     
     
     
170. SLAOUI M, Hepburn M
     Developing Safe and Effective Covid Vaccines - Operation Warp Speed's Strategy and Approach.
     N Engl J Med. 2020 Aug 26. doi: 10.1056/NEJMp2027405.
     PubMed    
     
     
     
171. JACKSON LA, Roberts PC, Graham BS
     A SARS-CoV-2 mRNA Vaccine - Preliminary Report. Reply.
     N Engl J Med. 2020;383.
     PubMed    
     
     
     
172. SCHAEFER JR, Sharkova Y, Nickolaus T
     A SARS-CoV-2 mRNA Vaccine - Preliminary Report.
     N Engl J Med. 2020;383.
     PubMed    
     
     
     
173. SCHACHAR RA, Schachar IH
     A SARS-CoV-2 mRNA Vaccine - Preliminary Report.
     N Engl J Med. 2020;383.
     PubMed    
     
     
     
174. RUBIN EJ, Baden LR, Morrissey S
     Audio Interview: Building a Successful Public Health Response to Covid-19.
     N Engl J Med. 2020;383:e67.
     PubMed    
     
     
     July 2020
175. RUBIN EJ, Baden LR, Piot P, Morrissey S, et al
     Audio Interview: New SARS-CoV-2 Vaccine Results, with Peter Piot.
     N Engl J Med. 2020;383:e57.
     PubMed    
     
     
     
176. MADHI SA, Polack FP, Piedra PA, Munoz FM, et al
     Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants.
     N Engl J Med. 2020;383:426-439.
     PubMed     Abstract available
     
     
     
177. LOW JG, Ng JHJ, Ong EZ, Kalimuddin S, et al
     Phase 1 Trial of a Therapeutic Anti-Yellow Fever Virus Human Antibody.
     N Engl J Med. 2020;383:452-459.
     PubMed     Abstract available
     
     
     
178. CORBETT KS, Flynn B, Foulds KE, Francica JR, et al
     Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.
     N Engl J Med. 2020 Jul 28. doi: 10.1056/NEJMoa2024671.
     PubMed     Abstract available
     
     
     
179. RUBIN EJ, Baden LR, Morrissey S
     Audio Interview: Covid-19 Vaccine Development.
     N Engl J Med. 2020;383:e40.
     PubMed    
     
     
     
180. JACKSON LA, Anderson EJ, Rouphael NG, Roberts PC, et al
     An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.
     N Engl J Med. 2020 Jul 14. doi: 10.1056/NEJMoa2022483.
     PubMed     Abstract available
     
     
     
181. HEATON PM
     The Covid-19 Vaccine-Development Multiverse.
     N Engl J Med. 2020 Jul 14. doi: 10.1056/NEJMe2025111.
     PubMed    
     
     
     
182. WORSHAM C, Woo J, Jena AB
     Birth Month and Influenza Vaccination in Children.
     N Engl J Med. 2020;383:184-185.
     PubMed    
     
     
     
183. DEMING ME, Michael NL, Robb M, Cohen MS, et al
     Accelerating Development of SARS-CoV-2 Vaccines - The Role for Controlled Human Infection Models.
     N Engl J Med. 2020 Jul 1. doi: 10.1056/NEJMp2020076.
     PubMed    
     
     
     June 2020
184. MELLO MM, Silverman RD, Omer SB
     Ensuring Uptake of Vaccines against SARS-CoV-2.
     N Engl J Med. 2020 Jun 26. doi: 10.1056/NEJMp2020926.
     PubMed    
     
     
     
185. FULLER DH, Berglund P
     Amplifying RNA Vaccine Development.
     N Engl J Med. 2020;382:2469-2471.
     PubMed    
     
     
     
186. SCHWARTZ JL, Colgrove J
     The Vaccines for Children Program at 25 - Access, Affordability, and Sustainability.
     N Engl J Med. 2020;382:2277-2279.
     PubMed    
     
     
     May 2020
187. RUBIN EJ, Baden LR, Morrissey S
     Audio Interview: Capitalizing on Immune Responses to Covid-19.
     N Engl J Med. 2020;382:e93.
     PubMed    
     
     
     
188. FELDMANN H, Sprecher A, Geisbert TW
     Ebola.
     N Engl J Med. 2020;382:1832-1842.
     PubMed    
     
     
     April 2020
189. BISWAL S, Tricou V, Dean H
     Tetravalent Dengue Vaccine in Healthy Children. Reply.
     N Engl J Med. 2020;382:1770-1771.
     PubMed    
     
     
     
190. SWAMINATHAN S, Khanna N
     Tetravalent Dengue Vaccine in Healthy Children.
     N Engl J Med. 2020;382:1769-1770.
     PubMed    
     
     
     
191. SALVANA EM
     Tetravalent Dengue Vaccine in Healthy Children.
     N Engl J Med. 2020;382:1769.
     PubMed    
     
     
     
192. RUBIN EJ, Baden LR, Morrissey S
     Audio Interview: Approaches to Covid-19 Vaccines and Antivirals.
     N Engl J Med. 2020;382:e58.
     PubMed    
     
     
     
193. TAIT DR, Van Der Meeren O, Hatherill M
     A Trial of M72/AS01E Vaccine to Prevent Tuberculosis. Reply.
     N Engl J Med. 2020;382:1577.
     PubMed    
     
     
     
194. OTTENHOFF THM
     A Trial of M72/AS01E Vaccine to Prevent Tuberculosis.
     N Engl J Med. 2020;382:1576-1577.
     PubMed    
     
     
     March 2020
195. LURIE N, Saville M, Hatchett R, Halton J, et al
     Developing Covid-19 Vaccines at Pandemic Speed.
     N Engl J Med. 2020 Mar 30. doi: 10.1056/NEJMp2005630.
     PubMed    
     
     
     
196. PITTMAN PR, Weidenthaler H, Chaplin P
     A Modified Vaccine against Smallpox. Reply.
     N Engl J Med. 2020;382:1285-1286.
     PubMed    
     
     
     
197. ENGLER R, Cooper LT
     A Modified Vaccine against Smallpox.
     N Engl J Med. 2020;382:1285.
     PubMed    
     
     
     
198. ZUCKER JR, Rosen JB, Iwamoto M, Arciuolo RJ, et al
     Consequences of Undervaccination - Measles Outbreak, New York City, 2018-2019.
     N Engl J Med. 2020;382:1009-1017.
     PubMed     Abstract available
     
     
     
199. GERSHON AA, Edwards K, Orenstein W, Schaffner W, et al
     Freedom, Measles, and Freedom from Measles.
     N Engl J Med. 2020;382:983-985.
     PubMed    
     
     
     February 2020
200. FAUCI AS, Lane HC, Redfield RR
     Covid-19 - Navigating the Uncharted.
     N Engl J Med. 2020 Feb 28. doi: 10.1056/NEJMe2002387.
     PubMed    
     
     
     
201. GATES B
     Responding to Covid-19 - A Once-in-a-Century Pandemic?
     N Engl J Med. 2020 Feb 28. doi: 10.1056/NEJMp2003762.
     PubMed    
     
     
     January 2020
202. FOPPIANO PALACIOS C, Openshaw JJ, Travassos MA
     Influenza in U.S. Detention Centers - The Desperate Need for Immunization.
     N Engl J Med. 2020 Jan 29. doi: 10.1056/NEJMp1916894.
     PubMed    
     
     
     
203. HARRISON LH, Stephens DS
     Good News and Bad News - 4CMenB Vaccine for Group B Neisseria meningitidis.
     N Engl J Med. 2020;382:376-378.
     PubMed    
     
     
     
204. MARSHALL HS, McMillan M, Koehler AP, Lawrence A, et al
     Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia.
     N Engl J Med. 2020;382:318-327.
     PubMed     Abstract available
     
     
     
205. LADHANI SN, Andrews N, Parikh SR, Campbell H, et al
     Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England.
     N Engl J Med. 2020;382:309-317.
     PubMed     Abstract available
     
     
     
206. WU K, Mulholland EK, Edwards KM
     Choosing a Mass Immunization Program against Meningococcal B.
     N Engl J Med. 2020;382:379-382.
     PubMed    
     
     
     December 2019
207. MARKS F, Kim JH
     Parting the Clouds over Typhoid with a New Conjugate Vaccine.
     N Engl J Med. 2019;381:2262-2264.
     PubMed    
     
     
     
208. SHAKYA M, Colin-Jones R, Theiss-Nyland K, Voysey M, et al
     Phase 3 Efficacy Analysis of a Typhoid Conjugate Vaccine Trial in Nepal.
     N Engl J Med. 2019;381:2209-2218.
     PubMed     Abstract available
     
     
     November 2019
209. PITTMAN PR, Hahn M, Lee HS, Koca C, et al
     Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox.
     N Engl J Med. 2019;381:1897-1908.
     PubMed     Abstract available
     
     
     
210. BISWAL S, Reynales H, Saez-Llorens X, Lopez P, et al
     Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents.
     N Engl J Med. 2019 Nov 6. doi: 10.1056/NEJMoa1903869.
     PubMed     Abstract available
     
     
     October 2019
211. TAIT DR, Hatherill M, Van Der Meeren O, Ginsberg AM, et al
     Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis.
     N Engl J Med. 2019 Oct 29. doi: 10.1056/NEJMoa1909953.
     PubMed     Abstract available
     
     
     July 2019
212. STREBEL PM, Orenstein WA
     Measles.
     N Engl J Med. 2019;381:349-357.
     PubMed    
     
     
     
213. ILUNGA KALENGA O, Moeti M, Sparrow A, Nguyen VK, et al
     The Ongoing Ebola Epidemic in the Democratic Republic of Congo, 2018-2019.
     N Engl J Med. 2019;381:373-383.
     PubMed     Abstract available
     
     
     June 2019
214. PAULES CI, Marston HD, Fauci AS
     Measles in 2019 - Going Backward.
     N Engl J Med. 2019;380:2185-2187.
     PubMed    
     
     
     
215. CANTOR JD
     Mandatory Measles Vaccination in New York City - Reflections on a Bold Experiment.
     N Engl J Med. 2019 Jun 5. doi: 10.1056/NEJMp1905941.
     PubMed    
     
     
     
216. SILVERMAN RD, Opel DJ, Omer SB
     Vaccination over Parental Objection - Should Adolescents Be Allowed to Consent to Receiving Vaccines?
     N Engl J Med. 2019 Jun 5. doi: 10.1056/NEJMp1905814.
     PubMed    
     
     
     May 2019
217. THOMAS DL
     Global Elimination of Chronic Hepatitis.
     N Engl J Med. 2019;380:2041-2050.
     PubMed    
     
     
     January 2019
218. MUSHER DM, Abers MS, Corrales-Medina VF
     Acute Infection and Myocardial Infarction.
     N Engl J Med. 2019;380:171-176.
     PubMed    
     
     
     November 2018
219. HADDAD LB, Jamieson DJ, Rasmussen SA
     Pregnant Women and the Ebola Crisis.
     N Engl J Med. 2018 Nov 28. doi: 10.1056/NEJMp1814020.
     PubMed    
     
     
     
220. DAMON IK, Rollin PE, Choi MJ, Arthur RR, et al
     New Tools in the Ebola Arsenal.
     N Engl J Med. 2018;379:1981-1983.
     PubMed    
     
     
     
221. SLIFKA MK, Amanna IJ
     Dengue Serostatus and Dengue Vaccine Safety and Efficacy.
     N Engl J Med. 2018;379:1968.
     PubMed    
     
     
     
222. 
     H4:IC31 Vaccine or BCG Revaccination for Tuberculosis.
     N Engl J Med. 2018;379:1969.
     PubMed    
     
     
     
223. 
     Dengue Serostatus and Dengue Vaccine Safety and Efficacy.
     N Engl J Med. 2018;379:1968-1969.
     PubMed    
     
     
     October 2018
224. ANDREWS JR, Qamar FN, Charles RC, Ryan ET, et al
     Extensively Drug-Resistant Typhoid - Are Conjugate Vaccines Arriving Just in Time?
     N Engl J Med. 2018;379:1493-1495.
     PubMed    
     
     
     September 2018
225. ELMAKKI E
     Intussusception after Rotavirus Vaccination in Africa.
     N Engl J Med. 2018;379:1288.
     PubMed    
     
     
     
226. 
     Intussusception after Rotavirus Vaccination in Africa.
     N Engl J Med. 2018;379:1288-1289.
     PubMed    
     
     
     
227. BLOOM BR
     New Promise for Vaccines against Tuberculosis.
     N Engl J Med. 2018 Sep 25. doi: 10.1056/NEJMe1812483.
     PubMed    
     
     
     
228. VAN DER MEEREN O, Hatherill M, Nduba V, Wilkinson RJ, et al
     Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis.
     N Engl J Med. 2018 Sep 25. doi: 10.1056/NEJMoa1803484.
     PubMed     Abstract available
     
     
     August 2018
229. BLAKE IM, Pons-Salort M, Molodecky NA, Diop OM, et al
     Type 2 Poliovirus Detection after Global Withdrawal of Trivalent Oral Vaccine.
     N Engl J Med. 2018;379:834-845.
     PubMed     Abstract available
     
     
     
230. PALLANSCH MA
     Ending Use of Oral Poliovirus Vaccine - A Difficult Move in the Polio Endgame.
     N Engl J Med. 2018;379:801-803.
     PubMed    
     
     
     
231. PAULES CI, Marston HD, Bloom ME, Fauci AS, et al
     Tickborne Diseases - Confronting a Growing Threat.
     N Engl J Med. 2018;379:701-703.
     PubMed    
     
     
     July 2018
232. NEMES E, Geldenhuys H, Rozot V, Rutkowski KT, et al
     Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination.
     N Engl J Med. 2018;379:138-149.
     PubMed     Abstract available
     
     
     
233. LO B
     A Parallel Universe of Clinical Trials.
     N Engl J Med. 2018;379:101-103.
     PubMed    
     
     
     
234. VANNICE K, Wilder-Smith A, Hombach J
     Fractional-Dose Yellow Fever Vaccination - Advancing the Evidence Base.
     N Engl J Med. 2018 Jul 11. doi: 10.1056/NEJMp1803433.
     PubMed    
     
     
     June 2018
235. HAUG CJ
     Keeping Your Cool - Doing Ebola Research during an Emergency.
     N Engl J Med. 2018;378:2353-2355.
     PubMed    
     
     
     
236. SHINDE V, Fries L, Wu Y, Agrawal S, et al
     Improved Titers against Influenza Drift Variants with a Nanoparticle Vaccine.
     N Engl J Med. 2018;378:2346-2348.
     PubMed    
     
     
     
237. ROSENBAUM L
     Trolleyology and the Dengue Vaccine Dilemma.
     N Engl J Med. 2018 Jun 13. doi: 10.1056/NEJMp1804094.
     PubMed    
     
     
     
238. SRIDHAR S, Luedtke A, Langevin E, Zhu M, et al
     Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy.
     N Engl J Med. 2018 Jun 13. doi: 10.1056/NEJMoa1800820.
     PubMed     Abstract available
     
     
     April 2018
239. TATE JE, Mwenda JM, Armah G, Jani B, et al
     Evaluation of Intussusception after Monovalent Rotavirus Vaccination in Africa.
     N Engl J Med. 2018;378:1521-1528.
     PubMed     Abstract available
     
     
     March 2018
240. NUNES MC, Cutland CL, Madhi SA
     Influenza Vaccination during Pregnancy and Protection against Pertussis.
     N Engl J Med. 2018;378:1257-1258.
     PubMed    
     
     
     
241. LEFEVRE H, Moro MR, Lachal J
     The New HPV Vaccination Policy in France.
     N Engl J Med. 2018;378:1160.
     PubMed    
     
     
     
242. JOURDAIN G, Ngo-Giang-Huong N, Harrison L, Decker L, et al
     Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.
     N Engl J Med. 2018;378:911-923.
     PubMed     Abstract available
     
     
     February 2018
243. BINES JE, At Thobari J, Satria CD, Handley A, et al
     Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from Birth.
     N Engl J Med. 2018;378:719-730.
     PubMed     Abstract available
     
     
     
244. AHUKA-MUNDEKE S, Casey RM, Harris JB, Dixon MG, et al
     Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak - Preliminary Report.
     N Engl J Med. 2018 Feb 14. doi: 10.1056/NEJMoa1710430.
     PubMed     Abstract available
     
     
     
245. FERRERAS E, Chizema-Kawesha E, Blake A, Chewe O, et al
     Single-Dose Cholera Vaccine in Response to an Outbreak in Zambia.
     N Engl J Med. 2018;378:577-579.
     PubMed    
     
     
     
246. BOYLSTON AW
     The Myth of the Milkmaid.
     N Engl J Med. 2018;378:414-415.
     PubMed    
     
     
     January 2018
247. OPEL DJ, Sonne JA, Mello MM
     Vaccination without Litigation - Addressing Religious Objections to Hospital Influenza-Vaccination Mandates.
     N Engl J Med. 2018 Jan 31. doi: 10.1056/NEJMp1716147.
     PubMed    
     
     
     
248. MARGOLIS DM, Garcia JV
     Countering HIV - Three's the Charm?
     N Engl J Med. 2018;378:295-297.
     PubMed    
     
     
     December 2017
249. WEBBER BJ, Duncan JR, Costello AA
     Third Dose of MMR Vaccine for Mumps Control.
     N Engl J Med. 2017;377:2402-3.
     PubMed    
     
     
     
250. JENT P, Olah A, Sommerstein R
     Third Dose of MMR Vaccine for Mumps Control.
     N Engl J Med. 2017;377:2402.
     PubMed    
     
     
     
251. OSTERGAARD L, Vesikari T, Absalon J, Beeslaar J, et al
     A Bivalent Meningococcal B Vaccine in Adolescents and Young Adults.
     N Engl J Med. 2017;377:2349-2362.
     PubMed     Abstract available
     
     
     
252. 
     Third Dose of MMR Vaccine for Mumps Control.
     N Engl J Med. 2017;377:2402-2403.
     PubMed    
     
     
     November 2017
253. PAULES CI, Sullivan SG, Subbarao K, Fauci AS, et al
     Chasing Seasonal Influenza - The Need for a Universal Influenza Vaccine.
     N Engl J Med. 2017 Nov 29. doi: 10.1056/NEJMp1714916.
     PubMed    
     
     
     
254. QADRI F, Islam T, Clemens JD
     Cholera in Yemen - An Old Foe Rearing Its Ugly Head.
     N Engl J Med. 2017;377:2005-2007.
     PubMed    
     
     
     October 2017
255. SCHRICK L, Tausch SH, Dabrowski PW, Damaso CR, et al
     An Early American Smallpox Vaccine Based on Horsepox.
     N Engl J Med. 2017;377:1491-1492.
     PubMed    
     
     
     
256. KENNEDY SB, Bolay F, Kieh M, Grandits G, et al
     Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia.
     N Engl J Med. 2017;377:1438-1447.
     PubMed     Abstract available
     
     
     
257. TEBAS P, Roberts CC, Muthumani K, Reuschel EL, et al
     Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine - Preliminary Report.
     N Engl J Med. 2017 Oct 4. doi: 10.1056/NEJMoa1708120.
     PubMed     Abstract available
     
     
     September 2017
258. GLICKMAN G, Harrison E, Dobkins K
     Vaccination Rates among Younger Siblings of Children with Autism.
     N Engl J Med. 2017;377:1099-1101.
     PubMed    
     
     
     
259. HOLLAND SM, Pierce VM, Shailam R, Glomski K, et al
     Case 28-2017. A 13-Month-Old Girl with Pneumonia and a 33-Year-Old Woman with Hip Pain.
     N Engl J Med. 2017;377:1077-1091.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: